How to Appeal an Insurance Denial for Wegovy or Zepbound

Yes, you can appeal an insurance denial for Wegovy or Zepbound — and many appeals succeed. Insurers often deny GLP-1 medications on the first pass for reasons like missing documentation or prior authorization gaps, not because you genuinely don't qualify. A structured appeal with the right clinical evidence gives you a strong chance of reversal.

Why Do Insurers Deny Wegovy and Zepbound?

Understanding the reason for your denial is the most important first step. Your insurer is legally required to send you a written denial notice that explains the specific reason. Common denial reasons include:

• Prior authorization not submitted: Your prescriber may not have filed the required paperwork before your pharmacy processed the claim.
• Missing BMI or diagnosis documentation: Wegovy is FDA-approved for adults with a BMI ≥30, or ≥27 with at least one weight-related condition such as type 2 diabetes, hypertension, or high cholesterol. Zepbound carries the same thresholds per its FDA labeling. If your chart notes don't clearly document this, the insurer may deny on medical necessity grounds.
• Step therapy requirements: Some plans require you to try and fail a cheaper weight-loss intervention — such as a supervised diet program — before approving a GLP-1.
• Formulary exclusion: A growing number of employer-sponsored plans exclude weight-loss drugs entirely. This is a different problem that requires a different strategy (see below).
• Incorrect diagnosis code: A billing code mismatch — for example, coding for cosmetic weight loss rather than obesity as a chronic disease — can trigger automatic denial.

What Is the Step-by-Step Appeal Process?

The federal appeals process under the Affordable Care Act gives most insured Americans at least two levels of internal appeal plus an external review right. Here is how to move through each stage:

What Should a Letter of Medical Necessity Include?

Your prescriber's letter carries the most weight in any appeal. A strong letter will typically include all of the following elements:

• Your current BMI and weight-related diagnoses, referenced against FDA-approved indications
• Prior treatments attempted — including dietary counseling, supervised programs, or other medications — and their outcomes
• A statement of why Wegovy or Zepbound is medically necessary for your specific condition, not just preferable
• References to supporting clinical evidence, such as the STEP 1 trial (Wilding et al., NEJM 2021), which showed approximately 15% average body weight reduction with semaglutide, or the SURMOUNT-1 trial (Jastreboff et al., NEJM 2022), which showed approximately 20.9% average body weight reduction with tirzepatide
• Your prescriber's direct contact information for any follow-up questions from the insurer's medical reviewer

You can ask your prescriber's office for a draft and review it yourself before it is submitted. You are allowed to do this.

What If Your Plan Excludes Weight-Loss Drugs Entirely?

Formulary exclusions are a harder barrier. If your Summary of Benefits and Coverage document explicitly excludes obesity medications, a standard medical necessity appeal may not succeed — the issue is plan design, not clinical eligibility. In this situation, consider these options:

• Check your diagnosis carefully: If you have type 2 diabetes, your prescriber may be able to prescribe Ozempic (semaglutide) or Mounjaro (tirzepatide) for glycemic control, which are approved for diabetes and covered more broadly. These are different brand names of the same active ingredients but with different FDA indications.
• Open enrollment: Request your employer's HR department to review the plan exclusion. Some employers have added GLP-1 coverage after employee advocacy. The tide is shifting as workplace wellness data accumulates.
• Manufacturer savings programs: Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) each offer savings cards that can significantly reduce out-of-pocket costs for commercially insured patients who do not qualify for government programs.
• Patient assistance programs: Both manufacturers offer income-based assistance. Ask your prescriber's office or check directly with the manufacturer.

How Do You Build a Strong Appeal Packet?

When you submit your appeal, send everything in one organized package. Include:

1. A copy of your denial letter with the denial reason highlighted
2. Your Letter of Medical Necessity from your prescriber
3. Relevant chart notes documenting your BMI, diagnoses, and treatment history
4. Any lab results supporting weight-related comorbidities (e.g., HbA1c, lipid panel, blood pressure readings)
5. A brief personal cover letter in your own words explaining your situation clearly and calmly
6. Copies of published clinical guidelines, such as the Obesity Medicine Association guidelines on pharmacotherapy, if your prescriber recommends including them

Send everything via certified mail or through your insurer's secure online portal so you have a documented timestamp. Keep copies of everything.

Frequently Asked Questions

Every insurance situation is different, and the rules that apply to your plan depend on factors like whether it is ACA-regulated, employer self-funded, or a government program. Your prescriber is your most important ally in this process — contact their office before taking any step, and ask them to guide you on the clinical documentation that will make your appeal as strong as possible.